BACKGROUND: The genes Gremlin-1 (GREM1) and Noggin (NOG) are components of the bone morphogenetic protein 4 pathway, which has been implicated in craniofacial development. Both genes map to recently identified susceptibility loci (chromosomal region 15q13, 17q22) for nonsyndromic cleft lip with or without cleft palate (nsCL/P). The aim of the present study was to determine whether rare variants in either gene are implicated in nsCL/P etiology. METHODS: The complete coding regions, untranslated regions, and splice sites of GREM1 and NOG were sequenced in 96 nsCL/P patients and 96 controls of Central European ethnicity. Three burden and four nonburden tests were performed. Statistically significant results were followed up in a second case-control sample (n = 96, respectively). For rare variants observed in cases, segregation analyses were performed. RESULTS: In NOG, four rare sequence variants (minor allele frequency < 1%) were identified. Here, burden and nonburden analyses generated nonsignificant results. In GREM1, 33 variants were identified, 15 of which were rare. Of these, five were novel. Significant p-values were generated in three nonburden analyses. Segregation analyses revealed incomplete penetrance for all variants investigated. CONCLUSION: Our study did not provide support for NOG being the causal gene at 17q22. However, the observation of a significant excess of rare variants in GREM1 supports the hypothesis that this is the causal gene at chr. 15q13. Because no single causal variant was identified, future sequencing analyses of GREM1 should involve larger samples and the investigation of regulatory elements.
BACKGROUND: The genes Gremlin-1 (GREM1) and Noggin (NOG) are components of the bone morphogenetic protein 4 pathway, which has been implicated in craniofacial development. Both genes map to recently identified susceptibility loci (chromosomal region 15q13, 17q22) for nonsyndromic cleft lip with or without cleft palate (nsCL/P). The aim of the present study was to determine whether rare variants in either gene are implicated in nsCL/P etiology. METHODS: The complete coding regions, untranslated regions, and splice sites of GREM1 and NOG were sequenced in 96 nsCL/P patients and 96 controls of Central European ethnicity. Three burden and four nonburden tests were performed. Statistically significant results were followed up in a second case-control sample (n = 96, respectively). For rare variants observed in cases, segregation analyses were performed. RESULTS: In NOG, four rare sequence variants (minor allele frequency < 1%) were identified. Here, burden and nonburden analyses generated nonsignificant results. In GREM1, 33 variants were identified, 15 of which were rare. Of these, five were novel. Significant p-values were generated in three nonburden analyses. Segregation analyses revealed incomplete penetrance for all variants investigated. CONCLUSION: Our study did not provide support for NOG being the causal gene at 17q22. However, the observation of a significant excess of rare variants in GREM1 supports the hypothesis that this is the causal gene at chr. 15q13. Because no single causal variant was identified, future sequencing analyses of GREM1 should involve larger samples and the investigation of regulatory elements.
Authors: Lord Jephthah Joojo Gowans; Ganiyu Oseni; Peter A Mossey; Wasiu Lanre Adeyemo; Mekonen A Eshete; Tamara D Busch; Peter Donkor; Solomon Obiri-Yeboah; Gyikua Plange-Rhule; Alexander A Oti; Arwa Owais; Peter B Olaitan; Babatunde S Aregbesola; Fadekemi O Oginni; Seidu A Bello; Rosemary Audu; Chika Onwuamah; Pius Agbenorku; Mobolanle O Ogunlewe; Lukman O Abdur-Rahman; Mary L Marazita; A A Adeyemo; Jeffrey C Murray; Azeez Butali Journal: Cleft Palate Craniofac J Date: 2018-02-28
Authors: Jenna C Carlson; Margaret A Taub; Eleanor Feingold; Terri H Beaty; Jeffrey C Murray; Mary L Marazita; Elizabeth J Leslie Journal: Birth Defects Res Date: 2017-07-17 Impact factor: 2.344
Authors: Elizabeth J Leslie; Jenna C Carlson; John R Shaffer; Carmen J Buxó; Eduardo E Castilla; Kaare Christensen; Frederic W B Deleyiannis; Leigh L Field; Jacqueline T Hecht; Lina Moreno; Ieda M Orioli; Carmencita Padilla; Alexandre R Vieira; George L Wehby; Eleanor Feingold; Seth M Weinberg; Jeffrey C Murray; Mary L Marazita Journal: Am J Med Genet A Date: 2017-04-19 Impact factor: 2.578
Authors: Kerstin U Ludwig; Syeda Tasnim Ahmed; Anne C Böhmer; Nasim Bahram Sangani; Sheryil Varghese; Johanna Klamt; Hannah Schuenke; Pinar Gültepe; Andrea Hofmann; Michele Rubini; Khalid Ahmed Aldhorae; Regine P Steegers-Theunissen; Augusto Rojas-Martinez; Rudolf Reiter; Guntram Borck; Michael Knapp; Mitsushiro Nakatomi; Daniel Graf; Elisabeth Mangold; Heiko Peters Journal: PLoS Genet Date: 2016-03-11 Impact factor: 5.917
Authors: Max D Knickmeyer; Juan L Mateo; Priska Eckert; Eleni Roussa; Belal Rahhal; Aimee Zuniga; Kerstin Krieglstein; Joachim Wittbrodt; Stephan Heermann Journal: Open Biol Date: 2018-03 Impact factor: 6.411
Authors: Denise K Liberton; Payal Verma; Konstantinia Almpani; Peter W Fung; Rashmi Mishra; Snehlata Oberoi; Figen Ç Şenel; James K Mah; John Huang; Bonnie L Padwa; Janice S Lee Journal: J Dev Biol Date: 2020-01-28